118 related articles for article (PubMed ID: 32410176)
1. Increased CD44 Expression and MEK Activity Predict Worse Prognosis in Gastric Adenocarcinoma Patients Undergoing Gastrectomy.
Lin JX; Yoon C; Li P; Yu Q; Qiu SL; Zheng CH; Yoon SS; Huang CM
J Gastrointest Surg; 2021 May; 25(5):1147-1155. PubMed ID: 32410176
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Outcomes for Elderly Gastric Cancer Patients at Least 80 Years of Age Following Gastrectomy in the United States and China.
Lin JX; Yi BC; Yoon C; Li P; Zheng CH; Huang CM; Yoon SS
Ann Surg Oncol; 2018 Nov; 25(12):3629-3638. PubMed ID: 30218243
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Survival after Minimally Invasive Versus Open Gastrectomy for Gastric Adenocarcinoma: A Propensity Score-Matched Analysis of Patients in the United States and China.
Lu J; Yoon C; Xu B; Xie J; Li P; Zheng C; Huang C; Yoon SS
Ann Surg Oncol; 2020 Mar; 27(3):802-811. PubMed ID: 31894481
[TBL] [Abstract][Full Text] [Related]
4. Increased RhoA Activity Predicts Worse Overall Survival in Patients Undergoing Surgical Resection for Lauren Diffuse-Type Gastric Adenocarcinoma.
Chang KK; Cho SJ; Yoon C; Lee JH; Park DJ; Yoon SS
Ann Surg Oncol; 2016 Dec; 23(13):4238-4246. PubMed ID: 27364501
[TBL] [Abstract][Full Text] [Related]
5. Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma.
Winder T; Ning Y; Yang D; Zhang W; Power DG; Bohanes P; Gerger A; Wilson PM; Lurje G; Tang LH; Shah M; Lenz HJ
Int J Cancer; 2011 Sep; 129(5):1096-104. PubMed ID: 21105049
[TBL] [Abstract][Full Text] [Related]
6. Effect of complication grade on survival following curative gastrectomy for carcinoma.
Jiang N; Deng JY; Ding XW; Zhang L; Liu HG; Liang YX; Liang H
World J Gastroenterol; 2014 Jul; 20(25):8244-52. PubMed ID: 25009399
[TBL] [Abstract][Full Text] [Related]
7. Comparison of gastric cancer survival after R0 resection in the US and China.
Li P; Huang CM; Zheng CH; Russo A; Kasbekar P; Brennan MF; Coit DG; Strong VE
J Surg Oncol; 2018 Nov; 118(6):975-982. PubMed ID: 30332517
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
Zhu Z; Wang Y; Li F; Gao J; Han B; Wang R; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):149-155. PubMed ID: 30799537
[TBL] [Abstract][Full Text] [Related]
9. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
10. Prognostic importance of RASSF2 expression in patients with gastric cancer who had undergone radical gastrectomy.
Aydin D; Bilici A; Kayahan S; Yavuzer D; Basar M; Aliustaoglu M
Clin Transl Oncol; 2016 Jun; 18(6):608-16. PubMed ID: 26459248
[TBL] [Abstract][Full Text] [Related]
11. Expression of cell adhesion molecule CD44 in gastric adenocarcinoma and its prognostic importance.
Ghaffarzadehgan K; Jafarzadeh M; Raziee HR; Sima HR; Esmaili-Shandiz E; Hosseinnezhad H; Taghizadeh-Kermani A; Moaven O; Bahrani M
World J Gastroenterol; 2008 Nov; 14(41):6376-81. PubMed ID: 19009655
[TBL] [Abstract][Full Text] [Related]
12. CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach.
Cao X; Cao D; Jin M; Jia Z; Kong F; Ma H; Wang Y; Jiang J
BMC Gastroenterol; 2014 Sep; 14():157. PubMed ID: 25212506
[TBL] [Abstract][Full Text] [Related]
13. CD44(+) CD324(-) expression and prognosis in gastric cancer patients.
Cao L; Hu X; Zhang J; Liang P; Zhang Y
J Surg Oncol; 2014 Nov; 110(6):727-33. PubMed ID: 24910454
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy, p53, carcinoembryonic antigen expression and prognosis after D2 gastrectomy for gastric adenocarcinoma.
He MM; Zhang DS; Wang F; Wang ZQ; Luo HY; Ren C; Jin Y; Chen DL; Xu RH
World J Gastroenterol; 2014 Jan; 20(1):264-73. PubMed ID: 24415881
[TBL] [Abstract][Full Text] [Related]
15. Validation of the memorial Sloan-Kettering Cancer Center nomogram to predict disease-specific survival after R0 resection in a Chinese gastric cancer population.
Chen D; Jiang B; Xing J; Liu M; Cui M; Liu Y; Wang Z; Chen L; Yang H; Zhang C; Yao Z; Zhang N; Ji J; Qu H; Su X
PLoS One; 2013; 8(10):e76041. PubMed ID: 24146811
[TBL] [Abstract][Full Text] [Related]
16. Expression of moesin and CD44 is associated with poor prognosis in gastric adenocarcinoma.
Jung WY; Kang Y; Lee H; Mok YJ; Kim HK; Kim A; Kim BH
Histopathology; 2013 Oct; 63(4):474-81. PubMed ID: 23889297
[TBL] [Abstract][Full Text] [Related]
17. Systemic Inflammation Response Index (SIRI), cancer stem cells and survival of localised gastric adenocarcinoma after curative resection.
Li S; Lan X; Gao H; Li Z; Chen L; Wang W; Song S; Wang Y; Li C; Zhang H; Xue Y
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2455-2468. PubMed ID: 28828692
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic value of a predictive model comprising preoperative inflammatory response and nutritional indexes in patients with gastric cancer].
Wu LL; Cai MZ; Wang BG; Deng JY; Ke B; Zhang RP; Liang H; Wang XN
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jul; 26(7):680-688. PubMed ID: 37583026
[No Abstract] [Full Text] [Related]
19. LETM1 is a potential biomarker that predicts poor prognosis in gastric adenocarcinoma.
Li H; Piao L; Xu D; Xuan Y
Exp Mol Pathol; 2020 Feb; 112():104333. PubMed ID: 31705880
[TBL] [Abstract][Full Text] [Related]
20. Preoperative Tumor Markers Independently Predict Survival in Stage III Gastric Cancer Patients: Should We Include Tumor Markers in AJCC Staging?
Lin JX; Wang W; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Zheng CH; Huang CM; Zhou ZW; Li P
Ann Surg Oncol; 2018 Sep; 25(9):2703-2712. PubMed ID: 29971670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
